Expression of integrin and CD44 receptors recognising osteopontin in the normal and LPS-lesioned rat substantia nigra.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): Ailane S;Ailane S; Long P; Jenner P; Rose S
  • Source:
    The European journal of neuroscience [Eur J Neurosci] 2013 Aug; Vol. 38 (3), pp. 2468-76. Date of Electronic Publication: 2013 May 22.
  • Publication Type:
    Journal Article; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Wiley-Blackwell Country of Publication: France NLM ID: 8918110 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-9568 (Electronic) Linking ISSN: 0953816X NLM ISO Abbreviation: Eur J Neurosci Subsets: MEDLINE
    • Publication Information:
      Publication: : Oxford : Wiley-Blackwell
      Original Publication: Oxford, UK : Published on behalf of the European Neuroscience Association by Oxford University Press, c1989-
    • Subject Terms:
      Hyaluronan Receptors/*metabolism ; Integrins/*metabolism ; Osteopontin/*metabolism ; Substantia Nigra/*metabolism; Animals ; Dopaminergic Neurons/metabolism ; Integrin alphaV/metabolism ; Integrin beta1/metabolism ; Integrin beta3/metabolism ; Lipopolysaccharides/pharmacology ; Male ; Neuroglia/metabolism ; Rats ; Rats, Wistar ; Substantia Nigra/drug effects
    • Abstract:
      The multifunctional protein osteopontin (OPN) is expressed in the substantia nigra (SN) and protects nigral dopaminergic neurones against toxic insult in animal models of Parkinson's disease, although the mechanisms involved are uncertain. In the periphery, OPN regulates inflammatory processes by interacting with integrin and CD44 receptors but the presence and distribution of these sites in SN is unknown. We investigated the expression of integrin receptor subunits and CD44 receptors in the normal SN and after induction of inflammation by lipopolysaccharide (LPS), and their interaction with OPN. In normal rat SN, integrin αv , β3 and β1 , and CD44, receptors were expressed on neurones including TH-positive cells but not on glia. LPS administration induced a loss of TH-positive neurones in SN and increased expression of glial cells as shown by GFAP, OX-6 and ED-1 immunoreactivity. In LPS-lesioned SN, there was up-regulation of the expression of integrin β3 and CD44 receptors. Co-localisation studies showed that this related to their increased expression on OX-6-, ED-1- and GFAP-positive cells. Furthermore, OPN interacted with integrin and CD44 receptors in the normal rat SN as demonstrated by co-immunoprecipitation and pull-down techniques. These data show that integrin and CD44 receptors are present on neurones in normal rat SN and that they are up-regulated on glial cells following LPS-mediated inflammation in SN, suggesting that they are functionally important in the inflammatory process. The interaction of OPN with these receptors suggests a role in the neuroprotective effect of this protein in the LPS model of Parkinson's disease.
      (© 2013 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.)
    • Grant Information:
      G-0710 United Kingdom PUK_ Parkinson's UK
    • Contributed Indexing:
      Keywords: Parkinson's disease; brain; glia; inflammation; neuroprotection
    • Accession Number:
      0 (Hyaluronan Receptors)
      0 (Integrin alphaV)
      0 (Integrin beta1)
      0 (Integrin beta3)
      0 (Integrins)
      0 (Lipopolysaccharides)
      106441-73-0 (Osteopontin)
    • Publication Date:
      Date Created: 20130523 Date Completed: 20140219 Latest Revision: 20220129
    • Publication Date:
      20240829
    • Accession Number:
      10.1111/ejn.12231
    • Accession Number:
      23692556